Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07693660 · ClinicalTrials.gov registry record · NA
VergeRx for Smokers Not Ready to Quit
A NA study, sponsored by University of Virginia.
- Not yet
- Registry status
- NA
- Development phase
- 592
- Enrollment target
NCT07693660 is a NA study that has not yet begun recruiting, run by University of Virginia. The registered enrollment target is 592 participants.
The verdict
NCT07693660, a NA study, has not yet begun recruiting, sponsored by University of Virginia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 592 participants
- Enrollment target
Study Summary
This study uses a factorial optimization experiment to identify which treatment components help adults who smoke and are not ready to quit in the next 30 days (smokers not ready to quit, or SNRTQ) achieve smoking cessation. Participants are recruited through Federally Qualified Health Centers (FQHCs) in Virginia and West Virginia. All participants receive at least 8 weeks of nicotine replacement therapy (NRT) patch. Using a 2×2×2×2 factorial design, the study independently tests four components: a pharmacist-delivered behavioral program (VergeRx), a text-message support program (SmokefreeTXT), the addition of an NRT lozenge to the patch, and an extended 16-week course of the NRT patch versus the standard 8 weeks. The goal is to estimate the effect of each component on biochemically confirmed smoking abstinence so that an optimized treatment package can be assembled. The primary outcome is abstinence at 26 weeks; a secondary outcome is abstinence at 52 weeks.
Interventions
- BEHAVIORAL SmokefreeTXT
- BEHAVIORAL VergeRx
- DRUG NRT Lozenge (Combination)
- DRUG Extended NRT Patch (16 weeks)
- DRUG Standard NRT Patch (8 weeks)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2027-12-01 |
| Est. Completion | 2032-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07693660
The ClinicalTrials.gov registry entry for NCT07693660 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 592 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which SmokefreeTXT is the first listed.
NCT07693660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07693660 about?
NCT07693660 is a clinical study titled "VergeRx for Smokers Not Ready to Quit". This study uses a factorial optimization experiment to identify which treatment components help adults who smoke and are not ready to quit in the next 30 days (smokers not ready to quit, or SNRTQ) achieve smoking cessation. Participants are recruited through Federally Qualified Health Centers (FQHCs...
What is the current status of trial NCT07693660?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 592 participants. The study started on 2027-12-01. Estimated completion is 2032-11-01.
What interventions are being tested in trial NCT07693660?
The interventions under investigation include: SmokefreeTXT (BEHAVIORAL), VergeRx (BEHAVIORAL), NRT Lozenge (Combination) (DRUG), Extended NRT Patch (16 weeks) (DRUG), Standard NRT Patch (8 weeks) (DRUG).
Who is sponsoring clinical trial NCT07693660?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.